Redsense Medical AB (ST:REDS) — Market Cap & Net Worth
Market Cap & Net Worth: Redsense Medical AB (REDS)
Redsense Medical AB (ST:REDS) has a market capitalization of $6.02 Million (Skr55.91 Million) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #28308 globally and #626 in its home market, demonstrating a 11.11% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Redsense Medical AB's stock price Skr3.40 by its total outstanding shares 16444891 (16.44 Million). Also see REDS asset base for a full breakdown of the balance sheet.
Redsense Medical AB Market Cap History: 2019 to 2026
Redsense Medical AB's market capitalization history from 2019 to 2026. Data shows change from $20.24 Million to $6.02 Million (-12.25% CAGR). Also see Redsense Medical AB (REDS) cash conversion ratio for how efficiently the company converts equity into cash flow.
Redsense Medical AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Redsense Medical AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check REDS share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.45x
Redsense Medical AB's market cap is 0.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
36.74x
Redsense Medical AB's market cap is 36.74 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $65.09 Million | $14.44 Million | -$9.03 Million | 4.51x | N/A |
| 2021 | $43.54 Million | $9.36 Million | -$7.97 Million | 4.65x | N/A |
| 2022 | $16.78 Million | $14.34 Million | -$8.76 Million | 1.17x | N/A |
| 2023 | $13.45 Million | $24.97 Million | -$4.51 Million | 0.54x | N/A |
| 2024 | $12.57 Million | $28.18 Million | $342.00K | 0.45x | 36.74x |
Competitor Companies of REDS by Market Capitalization
Companies near Redsense Medical AB in the global market cap rankings as of September 19, 2026. Review Redsense Medical AB tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Redsense Medical AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Redsense Medical AB Historical Marketcap From 2019 to 2026
Between 2019 and today, Redsense Medical AB's market cap moved from $20.24 Million to $ 6.02 Million, with a yearly change of -12.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr6.02 Million | -18.07% |
| 2025 | Skr7.34 Million | -41.55% |
| 2024 | Skr12.57 Million | -6.58% |
| 2023 | Skr13.45 Million | -19.83% |
| 2022 | Skr16.78 Million | -61.46% |
| 2021 | Skr43.54 Million | -33.11% |
| 2020 | Skr65.09 Million | +221.58% |
| 2019 | Skr20.24 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Redsense Medical AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.02 Million USD |
| MoneyControl | $6.02 Million USD |
| MarketWatch | $6.02 Million USD |
| marketcap.company | $6.02 Million USD |
| Reuters | $6.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Redsense Medical AB
Redsense Medical AB (publ) develops a monitoring system to detect sign of a blood leak using patented fiber optic technology primarily in Europe, Canada, and the United States. The company offers Redsense System, a product that is used for monitoring and alarming in the case of blood leakage during hemodialysis treatment; and Redsense venous sensor patch, a noninvasive patch that consists of an o… Read more